« Who Will Grab Fastest Follower Slot in Pharma Market(s)? | Main | Big Ministry Meeting: Why are India Pharma Groups Selling to MNCs? »

05/27/2010

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b0133ef01c147970b

Listed below are links to weblogs that reference Glaxo Open Source Initiative May Mean 'Open Sesame' to New Malarial Drugs :

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

bigredbruce

An update from (Reuters) via Fierce Biotech this morning reports that AZ now will make 500,000 compounds available for study in this project also.
http://www.reuters.com/article/idUSLDE65R0FE20100628

bigredbruce

Following GSK's lead, Pfizer is also cut a collaborative agreement with Washington University making a number of drug candidates available. Fierce Biotech reports today (6/15/10) that Pfizer is also opening a rare disease unit similar to one announced by GSK in Feb 2010.
http://www.fiercebiotech.com/story/pfizer-creates-new-r-d-unit-rare-diseases/2010-06-15?utm_medium=rss&utm_source=rss
The orphans are coming the orphans are coming. See BRBB post April 8th.

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

April 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada